Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kimura, Osamu ^a   Kondo, Yasuteru ^a   Kogure, Takayuki ^a   Kakazu, Eiji ^a   Ninomiya, Masashi ^a   Iwata, Tomoaki ^a   Morosawa, Tatsuki ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CISPLATIN; EPITHELIAL CELL ADHESION MOLECULE; FLUOROURACIL; LEVOLEUCOVORIN; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; TUMOR ANTIGEN; TUMOR-ASSOCIATED ANTIGEN GA733;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURGERY; CELL STRAIN HEPG2; CHEMOEMBOLIZATION; CONTINUOUS INFUSION; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFUSION PUMP; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; TREATMENT DURATION; AGED; CARCINOMA, HEPATOCELLULAR; DRUG EFFECTS; DRUG RESISTANCE; HEPATITIS B VIRUS; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

AGED; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HEPATITIS B VIRUS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 84896126810     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/172913     Document Type: Article

References (25)

1. Lau W., Lai E. C. H., Hepatocellular carcinoma: current management and recent advances. Hepatobiliary and Pancreatic Diseases International 2008 7 3 237 257 2-s2.0-46049111422 (Pubitemid 351895383)
2. Minami Y., Kudo M., Radiofrequency ablation of hepatocellular carcinoma: current status. World Journal of Radiology 2010 2 11 417 424
3. Ando E., Tanaka M., Yamashita F., Kuromatsu R., Yutani S., Fukumori K., Sumie S., Yano Y., Okuda K., Sata M., Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Cancer 2002 95 3 588 595 2-s2.0-0036682065 10.1002/cncr.10694 (Pubitemid 34810185)
4. Kondo M., Morimoto M., Numata K., Nozaki A., Tanaka K., Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Japanese Journal of Clinical Oncology 2011 41 1 69 75 2-s2.0-78650795329 10.1093/jjco/hyq145
5. Hotte S. J., Hirte H. W., BAY 43-9006: early clinical data in patients with advanced solid malignancies. Current Pharmaceutical Design 2002 8 25 2249 2253 2-s2.0-0036402628 10.2174/1381612023393053 (Pubitemid 35189897)
6. Bruix J., Raoul J. L., Sherman M., Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial. Journal of Hepatology 2012 57 4 821 829
7. Bonnet D., Dick J. E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997 3 7 730 737 2-s2.0-0030789242 10.1038/nm0797-730 (Pubitemid 27298715)
8. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 2-s2.0-0037388204 10.1073/pnas.0530291100 (Pubitemid 36418143)
9. Singh S. K., Clarke I. D., Terasaki M., Bonn V. E., Hawkins C., Squire J., Dirks P. B., Identification of a cancer stem cell in human brain tumors. Cancer Research 2003 63 18 5821 5828 2-s2.0-0141842674 (Pubitemid 37187480)
10. Visvader J. E., Lindeman G. J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer 2008 8 10 755 768 2-s2.0-52549087785 10.1038/nrc2499
11. Yin S., Li J., Hu C., Chen X., Yao M., Yan M., Jiang G., Ge C., Xie H., Wan D., Yang S., Zheng S., Gu J., CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. International Journal of Cancer 2007 120 7 1444 1450 2-s2.0-33847686753 10.1002/ijc.22476 (Pubitemid 46355378)
12. Ma S., Chan K., Hu L., Lee T. K., Wo J. Y., Ng I. O., Zheng B., Guan X., Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007 132 7 2542 2556 2-s2.0-34249980343 10.1053/j.gastro.2007.04.025 (Pubitemid 46890873)
13. + cancer stem cells in human liver cancer. Cancer Cell 2008 13 2 153 166 2-s2.0-38549139140 10.1016/j.ccr.2008.01.013 (Pubitemid 351163165)
14. Haraguchi N., Ishii H., Mimori K., Tanaka F., Ohkuma M., Kim H. M., Akita H., Takiuchi D., Hatano H., Nagano H., Barnard G. F., Doki Y., Mori M., CD13 is a therapeutic target in human liver cancer stem cells. The Journal of Clinical Investigation 2010 120 9 3326 3339 2-s2.0-77956388547 10.1172/JCI42550
15. Yamashita T., Ji J., Budhu A., Forgues M., Yang W., Wang H., Jia H., Ye Q., Qin L., Wauthier E., Reid L. M., Minato H., Honda M., Kaneko S., Tang Z., Wang X. W., EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009 136 3 1012 1024 2-s2.0-60449087921
16. Terris B., Cavard C., Perret C., EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma. Journal of Hepatology 2010 52 2 280 281 2-s2.0-75549088882 10.1016/j.jhep.2009.10.026
17. Kimura O., Takahashi T., Ishii N., Inoue Y., Ueno Y., Kogure T., Fukushima K., Shiina M., Yamagiwa Y., Kondo Y., Inoue J., Kakazu E., Iwasaki T., Kawagishi N., Shimosegawa T., Sugamura K., Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines. Cancer Science 2010 101 10 2145 2155 2-s2.0-77957051282 10.1111/j.1349-7006.2010.01661.x
18. Maetzel D., Denzel S., Mack B., Canis M., Went P., Benk M., Kieu C., Papior P., Baeuerle P. A., Munz M., Gires O., Nuclear signalling by tumour-associated antigen EpCAM. Nature Cell Biology 2009 11 2 162 171 2-s2.0-59749103834 10.1038/ncb1824
19. Yamashita T., Forgues M., Wang W., Jin W. K., Ye Q., Jia H., Budhu A., Zanetti K. A., Chen Y., Qin L., Tang Z., Xin W. W., EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Research 2008 68 5 1451 1461 2-s2.0-40449099255 10.1158/0008-5472.CAN-07-6013 (Pubitemid 351346853)
20. Chemin I., Zoulim F., Hepatitis B virus induced hepatocellular carcinoma. Cancer Letters 2009 286 1 52 59 2-s2.0-70349253352 10.1016/j.canlet.2008.12.003
21. Arzumanyan A., Friedman T., Ng I. O. L., Clayton M. M., Lian Z., Feitelson M. A., Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Research 2011 71 10 3701 3708 2-s2.0-79956079665 10.1158/0008-5472.CAN-10-3951
22. Wang C., Yang W., Yan H., Luo T., Zhang J., Tang L., Wu F., Zhang H., Yu L., Zheng L., Li Y., Dong W., He Y., Liu Q., Zou S., Lin Y., Hu L., Li Z., Wu M., Wang H., Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. Hepatology 2012 55 1 108 120 2-s2.0-84155180684 10.1002/hep.24675
23. Chisari F. V., Ferrari C., Hepatitis B virus immunopathogenesis. Annual Review of Immunology 1995 13 29 60 2-s2.0-0028916425
24. Tanaka N., Moriya K., Kiyosawa K., Koike K., Gonzalez F. J., Aoyama T., PPAR α activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. The Journal of Clinical Investigation 2008 118 2 683 694 2-s2.0-38849184816 10.1172/JCI33594 (Pubitemid 351206557)
25. Kim H., Choi G. H., Na D. C., Ahn E. Y., Kim G. I., Lee J. E., Cho J. Y., Yoo J. E., Choi J. S., Park Y. N., Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. Hepatology 2011 54 5 1707 1717 2-s2.0-80055060696 10.1002/hep.24559